Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Pharma-Union Pharmaceutical is a specialized pharmaceutical company that combines traditional manufacturing of chemical preparations with advanced biotechnology research. The company is well-regarded for its expertise in complex oral solid dosage forms, including sustained-release technologies for anti-infective and cardiovascular medications. Through its strategic investment in the RNA Nanotechnology platform via its subsidiary, Nanobio Delivery Pharmaceutical, the company is developing a pipeline of targeted RNA-based therapeutics, particularly for cardiovascular and oncological applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Pharma-Union Pharmaceutical.